TranSenda and Harvard Clinical Research Institute Announce Office-Smart Deployment
News Jun 22, 2009
TranSenda International, LLC, announced the deployment of a clinical trial software solution for Harvard Clinical Research Institute (HCRI) that expands the products and services already under contract between the two parties.
HCRI was seeking to continue the process of simplifying its existing systems to manage and monitor various spreadsheets, information and documents related to their clinical trials. To accomplish this, HCRI has migrated from initially using TranSenda’s Clinical Trial Manager product to Office-Smart Clinical Trial Manager™ and Office-Smart Clinical Payment Manager™.
This subsequent deployment also included the purchase of ClinBUS Connector™ along with professional services to consolidate existing data sets into a single repository for clinical trial management and related operational data.
By adding Office-Smart solutions to its organization, HCRI can now take advantage of advanced capabilities that allow integration between Clinical Trial Manager and the Microsoft® Office System. Office-Smart solutions also use TranSenda’s innovative ClinBUS® data interchange technology to make data available through Microsoft SharePoint Server.
Among other advantages, ClinBUS enables the use of SharePoint data grids to connect Microsoft Excel spreadsheets and databases, including Microsoft Access, to Office-Smart solutions for data import or integration. With this new level of connectivity, HCRI can now use data for the creation of SharePoint websites and dashboards; and to make better use of their existing Microsoft Office tools, including Excel, Access, Outlook and Word.
In addition to consolidating Microsoft Excel spreadsheet data, HCRI will also be integrating Office-Smart Clinical Trial Manager with a number of Clinical Trial Data Management Systems, including Electronic Data Capture (EDC) system(s) as well as their web-based learning management system.
Huntsman Cancer Institute Joins National Clinical Trial Targeting AMLNews
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society (LLS). The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018